WHY DO ZACKIE ACHMAT, NATHAN GEFFEN

First Page		Document Content
Date: 2008-11-11 09:25:33 Chemistry Zidovudine Antiretroviral drug HIV AIDS Nevirapine Treatment Action Campaign Lamivudine Didanosine HIV/AIDS Medicine Health		WHY DO ZACKIE ACHMAT, NATHAN GEFFEN Add to Reading List Source URL: www.tig.org.za Download Document from Source Website File Size: 75,34 KB Share Document on Facebook

	COMMENTARY: EPIDEMIOLOGY AND SOCIAL SCIENCE Justice After AIDS Denialism: Should There Be Prosecutions and Compensation? Nathan Geffen, MSc DocID: 1qaC7 - View Document
	Study No. 7, AugustIn the Face of Crisis: The Treatment Action Campaign Fights Government Inertia with Budget Advocacy and Litigation Neil Overy1 At the turn of the millennium the South African government allocate DocID: 1ppoN - View Document
	Student Stop AIDS Campaign A tipping point for HIV? We have the tools, the knowledge and the diversity of experience that can bring an end to AIDS—all we are missing is the political will. And that’s where you come DocID: 1gEBt - View Document
	AFRICAN HUMAN RIGHTS LAW JOURNAL The governments obligation to provide anti-retrovirals to HIVpositive pregnant women in an African human rights context: The South African Nevirapine case DocID: 1g9Gw - View Document
	AFRICAN HUMAN RIGHTS LAW JOURNAL HIV/AIDS law and policy in Cameroon: Overview and challenges Atangcho Nji Akonumbo* Senior Lecturer in Law, Faculty of Laws and Political Science, University of DocID: 1fBss - View Document